Glassman Wealth Services Novo Nordisk A S Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $5,617 - $6,748	64 Added 1.1%	5,904 $610,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $440,695 - $966,970	4,846 Added 487.53%	5,840 $531,000
Q2 2023 Aug 08, 2023	SELL	$155.98 - $172.65 $31,040 - $34,357	-199 Reduced 16.68%	994 $160,000
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $233,447 - $280,722	-1,764 Reduced 59.66%	1,193 $189,000
Q4 2022 Feb 06, 2023	BUY	$102.55 - $135.33 $40,609 - $53,590	396 Added 15.46%	2,957 $400,000
Q3 2022 Nov 09, 2022	SELL	$95.28 - $116.93 $6,479 - $7,951	-68 Reduced 2.59%	2,561 $255,000
Q2 2022 Aug 04, 2022	BUY	$103.24 - $121.81 $4,542 - $5,359	44 Added 1.7%	2,629 $293,000
Q1 2022 Aug 23, 2022	BUY	$93.1 - $112.54 $25,137 - $30,385	270 Added 11.66%	2,585 $287,000
Q1 2022 Apr 14, 2022	BUY	$93.1 - $112.54 $1,303 - $1,575	14 Added 0.61%	2,315 $257,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $21,093 - $25,757	220 Added 10.57%	2,301 $258,000
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $6,753 - $8,529	80 Added 4.0%	2,081 $200,000
Q2 2021 Aug 04, 2021	SELL	$67.66 - $84.76 $2,571 - $3,220	-38 Reduced 1.86%	2,001 $168,000
Q1 2021 May 05, 2021	SELL	$67.06 - $75.82 $11,534 - $13,041	-172 Reduced 7.78%	2,039 $137,000
Q4 2020 Feb 04, 2021	SELL	$63.89 - $73.8 $9,583 - $11,070	-150 Reduced 6.35%	2,211 $154,000
Q3 2020 Nov 09, 2020	BUY	$63.69 - $70.22 $17,578 - $19,380	276 Added 13.24%	2,361 $164,000
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $117 - $135	-2 Reduced 0.1%	2,085 $137,000
Q1 2020 May 12, 2020	BUY	$49.46 - $64.78 $86,901 - $113,818	1,757 Added 532.42%	2,087 $126,000
Q4 2019 Feb 07, 2020	SELL	$49.86 - $58.26 $16,453 - $19,225	-330 Reduced 50.0%	330 $19,000
Q4 2018 Feb 06, 2019	SELL	$41.54 - $47.25 $8,515 - $9,686	-205 Reduced 23.7%	660 $30,000
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $3,039 - $3,330	65 Added 8.13%	865 $41,000
Q4 2017 Feb 06, 2018	SELL	$47.53 - $53.73 $17,110 - $19,342	-360 Reduced 31.03%	800 $43,000
Q2 2017 Aug 09, 2017	BUY	N/A	1,160	1,160 $50,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account